FOIDART, P., Yip, C., Radermacher, J., Blacher, S., Lienard, M., MONTERORUIZ, L., Maquoi, E., Montaudon, E., Chateau-Joubert, S., COLLIGNON, J., Coibion, M., Jossa, V., Marangoni, E., Noël, A., Sounni, N. E.* , & JERUSALEM, G.*. (2019). Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-18-1880 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Yip, C., Foidart, P., Somja, J., Truong, A., Lienard, M., Feyereisen, E., SCHROEDER, H., GOFFLOT, S., Donneau, A.-F., COLLIGNON, J., Delvenne, P., Sounni, N. E., Jerusalem, G., & Noël, A. (2017). MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib. British Journal of Cancer. doi:10.1038/bjc.2017.23 Peer Reviewed verified by ORBi |
FUDVOYE, J., Dehan, P., Lienard, M., Trooskens, G., GERARD, A., Bourguignon, J.-P., & PARENT, A.-S. (11 March 2016). Single nucleotide polymorphism in the promoter of the steroidogenic factor 1 (SF-1) gene after gestational exposure to Bisphenol A [Paper presentation]. 44 ème Congrès annuel de la société belge de pédiatrie. |